Norris Medicines Ltd
Norris Medicines Ltd Live Price Chart
Performance
| Previous Close | ₹ 18.24 |
| High | ₹ 19 |
| Volume | 5340 |
| 52W Range | ₹ 12 - ₹ 19.63 |
| Open | ₹ 19 |
| Low | ₹ 19 |
| Market Cap | ₹ 14.5 Cr |
Norris Medicines Ltd Technicals
| 20 Day | ₹ 15.678 |
| 50 Day | ₹ 15.364 |
| 100 Day | ₹ 15.092 |
| 200 Day | ₹ 15.194 |
| 20 Day | ₹ 15.356 |
| 50 Day | ₹ 15.596 |
| 100 Day | ₹ 14.839 |
| 200 Day | ₹ 14.673 |
Norris Medicines Ltd Fundamentals
| ROCE | 3.435 |
| P/E Ratio | -49.300 |
| P/B Ratio | 0.000 |
| Industry P/E | 0.000 |
| Debt to Equity | 51.202 |
| ROE | 1.852 |
| EPS | -0.370 |
| Dividend Yield | 0.000 |
| Book Value | -15.072 |
| Face Value | 10.000 |
Norris Medicines Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 8.1774487 | 5.8815144 | 5.6639948 | 8.3726401 | 9.4641753 |
| Total Expenses | 8.4580938 | 7.0595797 | 6.761873 | 9.5659179 | 11.6486785 |
| Profit After Tax | -0.2806451 | -1.2374909 | -1.1867501 | -1.7494739 | -3.263483 |
Norris Medicines Ltd Shareholding Pattern
| Promoter Holdings | 34.013 % |
| FIIs | 0.000 % |
| DIIs | 0.064 % |
| MutualFund | 0.005 % |
| Retail | 20.776 % |
| Others - | 45.142 % |
About Norris Medicines Ltd
Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on March 7, 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.'91. The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The project commence in March 1992. Thereafter, the Company came out with a Public Issue aggregating Rs. 5 Crore in December, 1993 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity, which got completed in 1995. In 2006, the Company launched Diabetic & Cardiac products; launched Dental product in 2007; launched New Molecule Tolperisone with Paracetamol tablet in 2012; in 2013, it extended Anti malarial range with Artemether Lumefantrine tablet & dry syrup. During the year 2013-14, the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and operate 2 plants situated at GIDC, Ankleshwar, Gujarat. Both ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 39.45 -1 (-2.47%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 494.30 +0.65 (+0.13%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,769.00 +17.6 (+0.26%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 675.00 -5.4 (-0.79%) |
| Abbott India Ltd Pharmaceuticals | ₹ 27,097.10 -176.2 (-0.65%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,393.70 +22.25 (+1.62%) |
FAQs on Norris Medicines Ltd
1. Can I buy Norris Medicines Ltd from PL Capital? ›
2. Does Norris Medicines Ltd pay dividends? ›
3. What is the current share price of Norris Medicines Ltd ? ›
4. What is the 52-week high and low of Norris Medicines Ltd ? ›
5. What is the market capitalisation of Norris Medicines Ltd? ›
6. What is the current P/E ratio of Norris Medicines Ltd? ›
7. What is the current P/B ratio of Norris Medicines Ltd? ›
8. What is the shareholding pattern of Norris Medicines Ltd? ›
9. What is the 1-year return of Norris Medicines Ltd? ›
Start SIP in Norris Medicines Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
